tldrdailynews.com logo
Tag

Masimo

All articles tagged with #masimo

Apple’s $634M patent verdict seals Masimo saga, now under Danaher
technology1 month ago

Apple’s $634M patent verdict seals Masimo saga, now under Danaher

Apple must pay Masimo $634 million after a court rejected its appeal over sensor patents tied to the Apple Watch blood oxygen sensor. Masimo’s bid to block sales failed, and Apple had already bypassed a ban via a 2024 software update. Danaher acquired Masimo in 2026 for $9.9B, positioning the payout as a windfall for the new owners, while the patents are set to expire in 2028–2029. The judge denied further judgments or a new trial, making the verdict largely final, though appeals remain uncertain.

via AppleInsider|
#apple#danaher#litigation
business6 months ago

Danaher to Buy Masimo for $180/Share in a $9.9B Acquisition

Danaher will acquire Masimo for $180 per share in cash, valuing the deal at about $9.9 billion. The boards have approved the transaction, Masimo will become a standalone business unit and brand within Danaher’s Diagnostics segment, and the deal is expected to close in the second half of 2026 subject to regulatory approvals and other customary closing conditions.

via Business Wire|
#acquisition#business#danaher
business6 months ago

Danaher to Acquire Masimo in a $9.9 Billion Diagnostics Play

Danaher announced a definitive agreement to acquire Masimo for $180 per share in cash, valuing Masimo at about $9.9 billion including debt and net cash. The deal, which translates to roughly 18x 2027 EBITDA (or 15x with expected synergies), would make Masimo a standalone operating company within Danaher’s Diagnostics segment. Masimo is expected to be accretive to adjusted diluted EPS by $0.15–$0.20 in the first full year and about $0.70 in year five, with long-term high-single-digit core revenue growth and over $530 million in EBITDA in 2027. Danaher also expects more than $125 million of annual cost synergies and over $50 million of annual revenue synergies by the fifth full year post-close. The transaction is targeted to close in the second half of 2026, subject to regulatory approvals, Masimo shareholder approval, and other customary conditions; financing will come from cash on hand and debt. Advisors named include Citi and Goldman Sachs for Danaher, with Kirkland & Ellis as legal counsel.

via Danaher Corporation Investors|
#acquisition#business#danaher
Masimo sues US Customs over Apple Watch blood oxygen feature
technology1 year ago

Masimo sues US Customs over Apple Watch blood oxygen feature

Masimo has filed a lawsuit against US Customs and Border Protection, alleging they overstepped their authority by reversing a decision that allowed Apple to reintroduce the Blood Oxygen feature on the Apple Watch, which Masimo claims infringes on its patents. The company seeks a court order to reinstate the original ruling and prevent the feature's reintroduction via software updates.

via 9to5Mac|
#apple-watch#blood-oxygen#lawsuit
Masimo Files Lawsuit Against Customs Over Apple Watch Oxygen Feature
law-and-technology1 year ago

Masimo Files Lawsuit Against Customs Over Apple Watch Oxygen Feature

Masimo has sued US Customs and Border Protection, claiming it unlawfully reversed a decision that allowed Apple to restore a blood-oxygen monitoring feature on Apple Watches, which Masimo alleges infringes its patents. The company seeks to block the enforcement of CBP's recent ruling and restore the original decision that restricted imports of Apple Watches with the feature enabled, arguing the reversal was unlawful and violated procedural policies.

via Bloomberg Law News|
#apple-watch#blood-oxygen#cbp
Apple and Masimo Clash Again in Court Over Smartwatch Sensor Technology
technology1 year ago

Apple and Masimo Clash Again in Court Over Smartwatch Sensor Technology

Apple and Masimo are engaged in a legal battle over alleged trade secret theft and patent infringement related to the Apple Watch's blood oxygen sensing feature. Masimo accuses Apple of poaching employees and stealing technology, seeking an injunction rather than monetary damages. Despite an ITC ruling against Apple, which led to disabling the feature in U.S. sales, Apple continues to appeal. Masimo's legal efforts have yet to significantly impact Apple's business.

via MacRumors|
#apple#apple-watch#lawsuit
"Ultimate Guide to the Apple Watch Ban: Key Facts and Updates"
technology2 years ago

"Ultimate Guide to the Apple Watch Ban: Key Facts and Updates"

The Apple Watch Series 9 and Ultra 2 are facing an ITC situation due to patent infringement, resulting in a ban on their sale in the United States. Apple is still selling the devices with the blood oxygen features disabled, and third-party retailers continue to offer them with the features intact. The ITC's decision has led to a series of legal maneuvers and appeals from Apple, including a redesign and a software update to address the issue. The situation remains ongoing, with the US appeals court temporarily halting the ban, while the Biden administration upholds the ITC's ruling.

via 9to5Mac|
#apple#apple-watch#itc
"Apple's Extensive Appeal Against Apple Watch Ban"
technology2 years ago

"Apple's Extensive Appeal Against Apple Watch Ban"

Apple has filed a 916-page appeal to the Federal Circuit over the ban on sales of Apple Watch Series 9 and Ultra 2, which was imposed by the International Trade Commission due to patent infringement claims by medical device-maker Masimo. Apple's appeal argues that Masimo lacked an actual smartwatch and domestic industry at the time of the complaint, and questions the jurisdiction of the ITC. The appeal raises concerns about the potential implications of the decision and highlights the ongoing legal battles between tech companies and the ITC.

via The Verge|
#apple#apple-watch#international-trade-commission